Kim Ji-Hyun, Kim Sun Yeou, Lee Seok-Yong, Jang Choon-Gon
Department of Pharmacology, College of Pharmacy, Sungkyunkwan University, Suwon 440-746, Republic of Korea.
Pharmacol Biochem Behav. 2007 May;87(1):41-7. doi: 10.1016/j.pbb.2007.03.018. Epub 2007 Apr 6.
The present study was undertaken to investigate the antidepressant-like effects of the methylene chloride fraction of Albizzia julibrissin (MCAJ) using a tail suspension test in mice. MCAJ was orally administered at 50, 100, or 200 mg/kg to mice, 1 h before the tail suspension test. Acute treatment with MCAJ at 200 mg/kg significantly reduced the immobility time compared with the control group, and thus showed an antidepressant-like effect. This effect was comparable to that of imipramine at 10 mg/kg. This antidepressant-like effect was reversed by treatment with WAY-100635 (a 5-HT1A receptor antagonist) or pindolol (a 5-HT1A/1B receptor antagonist). However, the antidepressant effect of MCAJ was not effected by treatment with GR55562 (a 5-HT1B receptor antagonist) or ketanserin (a 5-HT2A receptor antagonist). Therefore, our findings suggest that MCAJ exerts its antidepressant-like effect via the 5-HT1A receptor system.
本研究旨在利用小鼠悬尾实验探究合欢皮二氯甲烷提取物(MCAJ)的抗抑郁样作用。在悬尾实验前1小时,分别以50、100或200mg/kg的剂量给小鼠口服MCAJ。与对照组相比,200mg/kg的MCAJ急性给药显著缩短了不动时间,从而表现出抗抑郁样作用。该作用与10mg/kg的丙咪嗪相当。用WAY-100635(一种5-HT1A受体拮抗剂)或吲哚洛尔(一种5-HT1A/1B受体拮抗剂)处理可逆转这种抗抑郁样作用。然而,GR55562(一种5-HT1B受体拮抗剂)或酮色林(一种5-HT2A受体拮抗剂)处理并未影响MCAJ的抗抑郁作用。因此,我们的研究结果表明,MCAJ通过5-HT1A受体系统发挥其抗抑郁样作用。